San Diego, CA, United States of America

Marianne Patch


Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 31(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Spotlight: Marianne Patch

Introduction

Marianne Patch is a notable inventor based in San Diego, California, recognized for her significant contributions to biotechnology. With one patent to her name, her work primarily focuses on the advancements in therapeutic uses pertaining to phenylalanine imbalances within human and animal bodies.

Latest Patents

Marianne Patch holds a patent titled "Variants and chemically-modified variants of phenylalanine ammonia-lyase." This invention relates to the use of the enzyme phenylalanine ammonia-lyase and its biologically active derivatives in preventing or treating diseases linked to phenylalanine imbalance. It encompasses the development of therapeutic compositions containing these active molecules and outlines methodologies for selecting more effective variants of the protein.

Career Highlights

Throughout her career, Marianne has worked with esteemed companies such as BioMarin Pharmaceutical Inc. and The Scripps Research Institute. Her professional journey demonstrates a commitment to understanding and innovating in the field of pharmacology and therapeutic applications.

Collaborations

Marianne Patch has collaborated with significant figures in the industry, including Emilio Kakkis and Daniel I Oppenheimer. These collaborations have fostered growth and advancement in her research and led to impactful developments in her field.

Conclusion

Marianne Patch exemplifies dedication to innovation in biochemistry and therapeutic solutions. Her patent reflects her contributions toward understanding the implications of phenylalanine imbalances, highlighting the importance of continued research and collaboration in the realm of health sciences. Her journey serves as an inspiration for future inventors and researchers striving to create impactful solutions for complex biological challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…